The MACH presents funding opportunities for researchers across its partnership primarily through the Medical Research Future Fund (MRFF)'s Rapid Applied Research Translation (RART) grants scheme, an allocation from the Department of Health.
We also fund translational pilot and proof-of-concept research projects, as well as work that supports our national collaboration in important focus areas.
MRFF Rapid Applied Research Translation Scheme
Beginning in 2017, the MACH has funded Transformative Translational Research projects through its MRFF "Rapid Applied Research Translation (RART)" funding. All projects are to align with the Medical Research and Innovation Priorities and the Medical Research and Innovation Strategy 2016-2021 and demonstrate clear evidence of translational outcomes to with an aim of improving health outcomes and driving health system reform.
This funding is distinct from other MRFF funding streams and is only available via the MACH to its partners.
Rapid Applied Research Translation Grant Scheme
The aim of this scheme is to:
improve patient experience by improving care pathways and service connections;
reduce unwarranted variation in healthcare and patient outcomes;
improve the health of certain at-risk groups in Australia, such as Indigenous Australians; and
support innovative clinical trials.
The MACH offers these funding opportunities to MACH partner-affiliated researchers to support translational research projects that would produce tangible outcomes of value to the health system within a short time frame of 12 to 24 months.